|
Acute Cerebral Infarction
Citations 191-200 of 2654 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Treating Patients With Ischemic Stroke With Tissue Plasminogen Activator in the 3.5- to 4-Hour Window. Numbers Support Benefit but the Message Is to Still Go Fast
- Tobias Kurth and Christophe Tzourio
Stroke published June 4, 2009, doi:10.1161/STROKEAHA.109.552398
[Abstract]
- Articles
Stroke Incidence and Mortality Rates 1987 to 2006 Related to Secular Trends of Cardiovascular Risk Factors in Gothenburg, Sweden
- Per Harmsen, Lars Wilhelmsen, and Anders Jacobsson
Stroke published June 4, 2009, doi:10.1161/STROKEAHA.109.550814
[Abstract]
- Articles
Risk Assessment of Symptomatic Intracerebral Hemorrhage After Thrombolysis Using DWI-ASPECTS
- Oliver C. Singer, Wiebke Kurre, Marek C. Humpich, Matthias W. Lorenz, Andreas Kastrup, David S. Liebeskind, Goetz Thomalla, Jens Fiehler, Joachim Berkefeld, Tobias Neumann-Haefelin for the MR Stroke Study Group Investigators
Stroke published June 4, 2009, doi:10.1161/STROKEAHA.109.550111
[Abstract]
- Articles
Cerebral Ischemic Events Associated With ‘Bubble Study’ for Identification of Right to Left Shunts
- José R. Romero, James L. Frey, Lee H. Schwamm, Bart M. Demaerschalk, Hari P. Chaliki, Gunjan Parikh, Robert F. Burke, and Viken L. Babikian
Stroke published June 4, 2009, doi:10.1161/STROKEAHA.109.549683
[Abstract]
- Articles
High Risk of Early Neurological Recurrence in Symptomatic Carotid Stenosis
- Angel Ois, Elisa Cuadrado-Godia, Ana Rodríguez-Campello, Jordi Jimenez-Conde, and Jaume Roquer
Stroke published June 4, 2009, doi:10.1161/STROKEAHA.109.548032
[Abstract]
- Articles
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window. Joint Outcome Table Analysis of the ECASS 3 Trial
- Jeffrey L. Saver, Jeffrey Gornbein, James Grotta, David Liebeskind, Helmi Lutsep, Lee Schwamm, Phillip Scott, and Sidney Starkman
Stroke published June 4, 2009, doi:10.1161/STROKEAHA.108.543561
[Abstract]
- Comments, Opinions, and Reviews
Clinical Trials, Devices, Unproven Treatments, and Clinical Equipoise
- Warren W. Wasiewski and Karen C. Johnston
Stroke 2009;40:e441-442e; published online before print as doi:10.1161/STROKEAHA.108.531939
[Full text]
- Comments, Opinions, and Reviews
Hemodynamic Factors and Perfusion Abnormalities in Early Neurological Deterioration
- Josef A. Alawneh, Ramez Reda Moustafa, and Jean-Claude Baron
Stroke 2009;40:e443-450e; published online before print as doi:10.1161/STROKEAHA.108.532465
[Abstract]
[Full text]
- Original Contributions
Causes and Severity of Ischemic Stroke in Patients With Symptomatic Intracranial Arterial Stenosis
- Bolanle M. Famakin, Marc I. Chimowitz, Michael J. Lynn, Barney J. Stern, Mary G. George for the WASID Trial Investigators
Stroke 2009;40:1999-2003; published online before print as doi:10.1161/STROKEAHA.108.546150
[Abstract]
[Full text]
- Original Contributions
Dispatcher Recognition of Stroke Using the National Academy Medical Priority Dispatch System
- Brian H. Buck, Sidney Starkman, Marc Eckstein, Chelsea S. Kidwell, Jill Haines, Rainy Huang, Daniel Colby, and Jeffrey L. Saver
Stroke 2009;40:2027-2030; published online before print as doi:10.1161/STROKEAHA.108.545574
[Abstract]
[Full text]
|
|
